ARRB2 and chronic myelogenous leukemia, BCR-ABL1 positive: Importantly, depletion of ARRB2 significantly reduced the level of activated β-catenin suggesting that ARRB2 also plays a key role in regulating the Wnt/Frizzled pathway in CML [16].